Jacci Bainbridge
University of Colorado Denver
3 Papers
4 Citations
Jacci Bainbridge is an academic researcher from University of Colorado Denver. The author has contributed to research in topics: Randomized controlled trial & Placebo. The author has an hindex of 3, co-authored 3 publications.
Chat about Author
Papers
Pioglitazone in early Parkinson's disease: a phase 2, multicentre, double-blind, randomised trial
Tanya Simuni,Karl Kieburtz,Barbara C. Tilley,Jordan J. Elm,Bernard Ravina,Debra Babcock,Marina E. Emborg,Robert A. Hauser,Cornelia Kamp,John C. Morgan,G. Webster Ross,David Simon,Jacci Bainbridge,Liana Baker,Ivan Bodis-Wollner,James T. Boyd,Franca Cambi,Julie H. Carter,Kelvin L. Chou,Nabila Dahodwala,Richard B. Dewey,Rohit Dhall,John Y. Fang,Buff Farrow,Andrew Feigin,Sofya Glazman,John L. Goudreau,Pauline LeBlanc,Stephen L. Lee,Maureen A. Leehey,Mark F. Lew,Stephanie Lowenhaupt,Sheng Luo,Rajesh Pahwa,Adriana Pérez,Jay S. Schneider,Burton L. Scott,Binit B. Shah,Kathleen M. Shannon,Saloni Sharma,Carlos Singer,Daniel D. Truong,Renee Wagner,Karen Williams,Anne-Marie Wills,Pei Shieen Wong,Pei Shieen Wong,Cindy Zadikoff,Richard M. Zweig +48 more
TL;DR: It is suggested that pioglitazone at the doses studied here is unlikely to modify progression in early Parkinson's disease.
A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease
Karl Kieburtz,Bernard Ravina,Bernard Ravina,Wendy R. Galpern,Barbara C. Tilley,Kathleen M. Shannon,Caroline M. Tanner,G. Frederick Wooten,Robert W. Hamill,Jacob I. Sage,Emily Kosa,Ray L. Watts,Natividad R. Stover,Rebecca McMurray,Mark F. Lew,Connie Kawai,David Coffey,Pauline LeBlanc,Julie H. Carter,Matthew Brodsky,Pamela Andrews,Andrew Siderowf,Sue Reichwein,Lisa M. Shulman,William J. Weiner,Katharine Pabst,Jeana Jaglin,Robert A. Hauser,Theresa McClain,Holly Delgado,Oksana Suchowersky,Lorelei Derwent,Jayaraman Rao,Maureen Cook,Michael J. Aminoff,Chad W. Christine,Jessie Roth,Maureen A. Leehey,Jacci Bainbridge,G. Webster Ross,Stephanie Terashita,Carlos Singer,Marian A. Perez,Anita Blenke,Brad A. Racette,Patricia Deppen,Rodger J. Elble,Charlene Young,Tracy Stewart,Kapil D. Sethi,Buff Dill,John W. Taylor,Peggy Roberge,Richard B. Dewey,Brigid Hayward,Joseph Jankovic,Christine Hunter,Frederick Wooten,Margaret F. Keller,Danna Jennings,Tammie Kelsey,W.R. Wayne Martin,Germaine McInnes,Joanne Wojcieszek,Joann Belden,Roger L. Albin,Kristine Wernette,Joseph M. Savitt,Becky Dunlop,Rajesh Pahwa,Kelly E. Lyons,Amy Parsons,John Y. Fang,Dorothy Shearon,Andrew Feigin,Margaret Marie Cox,Charles H. Adler,Marlene Lind,Burton L. Scott,Joanne Field,Martha Nance,Susan Peterson,Richard S. Burns,Lynn Marlor,I. Van Bodis-Wollner,Elizabeth Hayes,Jay S. Schneider,Stephanie Sendek,Stephen Gollomp,Gwyn Vernon,Peter A LeWitt,Maryan DeAngelis,David Simon,Linda Paul,Jay M. Gorell,Shana Krstevska,Marilyn Flewellen,Sharon McCarthy,Ryan J. Uitti,Margaret F. Turk,James H. Bower,Susan Torgrimson,Marwan N. Sabbagh,Zoran Obradov,Jorge L. Juncos,Mary Louise Musante Weeks,Hubert H. Fernandez,Gordon H. Brown,Jordan J. Elm,Paulo Guimaraes,Peng Huang,Yuko Y. Palesch,Cornelia Kamp,Aileen Shinaman,Debbie Fraser,Alicia Brocht,Susan Bennett,Chris Weaver,Debbie Baker,Beverly Olsen,Christopher G. Goetz,Janis M. Miyasaki,Susan C. Fagan,Patrick D. Mauldin +123 more
TL;DR: Coenzyme Q10 and GPI-1485 may warrant further study in Parkinson disease, although the data are inconsistent, and additional factors should be considered in the selection of agents for Phase III studies.
225
Use of diagnostic tests and procedures for disease-modifying therapy users and non-disease-modifying therapy users with multiple sclerosis.
Kavita V. Nair,John R. Corboy,Kristijan H. Kahler,Richard R. Allen,Vahram Ghushcyan,Robert Brett McQueen,Jacci Bainbridge,Homa B. Dastani,Nikita Mody-Patel +8 more
TL;DR: In this article, the use of 23 diagnostic procedures and monitoring tests for users of DMT and non-DMT users with multiple sclerosis (MS) was examined, and Logistic regression models were used to estimate differences in rates and proportion of patients receiving procedures and tests between cohorts.
4